# Forensic Dossier: Study Forensics: APJ agonist as pharmacological exercise mimetic

**Run ID:** `mechfix_study-forensics-030_Claude_Sonnet_02dd22`  
**Task:** study-forensics-030 | study_forensics | medium | study_forensics  
**Timestamp:** 2026-04-08T16:42:21.940009+00:00  
**Task Family:** mechanism_vs_evidence  
**Trap Type:** preclinical_to_therapeutic_leap  
**Ambiguity:** low  

## Executive Summary

**Agents tested:** Claude Sonnet
**Winner:** Claude Sonnet — **72.8/100** (margin: 0.0)
**Failure modes:** decorative_uncertainty
**Forensic flags:** 1
**Consistency findings:** 6
**Answer convergence:** all agents agree

## Score Matrix

| Agent | Correctness | Support Strength | Structural Reaso | Assumption Disci | Uncertainty Hand | Alternative Hypo | Self Monitoring  | Insight Depth | Mechanism Qualit | Communication Ef | **Total** |
|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|-------|
| Claude Sonnet | 30.0/30 | 2.4/8 | 5.3/8 | 4.8/6 | 3.6/6 | 4.5/6 | 1.2/8 | 8.0/8 | 3.0/10 | 10.0/10 | **72.8/100** |

## Study Forensics Audit

### Claude Sonnet

**Classification:** `mechanism_vs_evidence` [+] (gold: `mechanism_vs_evidence`)
**Finding Recall:** 100%
**Matched Findings:** mechanism_not_demonstrated, conclusion_exceeds_results
**Extra Findings:** cautious_scope_control, unsupported_generalization

## Reasoning Integrity Audit

### Claude Sonnet
**Classification:** Correct and well-supported
**Load-bearing steps:** 1 / 6

## Mechanism Analysis

### Claude Sonnet
| Aspect | Status |
|--------|--------|
| Concept named | :x: none |
| Mechanism described | :white_check_mark: (1 sentence(s)) |
| Grounded to case | :x: (0 sentence(s)) |

**Missing:** concept not named, mechanism not grounded to case data

## Grounding Audit

### Claude Sonnet
Conclusion claims: 1
- Direct support: 0
- Indirect support: 1
- Unsupported: 0
- Contradicted: 0


## Forensic Flags

### Claude Sonnet

- **[STYLISTIC]** `unnamed_mechanism`: Describes mechanism without naming the concept — under-explicit
  - `steps[5]`: "Classified as mechanism_vs_evidence due to unsupported leap from animal evidence to human therapeuti"


## Evidence Map

### Claude Sonnet

**Correctness:** 30.0/30
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Agent's answer for correctness check_
  - Note: Exact match

**Support Strength:** 2.4/8
  - (+) `final_answer`: "mechanism_vs_evidence"
    _Conclusion grounded by reasoning chain_
  - Note: Support classification: 0 load-bearing, 1 supporting, 0 mentioned / 6
  - Note: Reasoning graph confirms conclusion grounding

**Structural Reasoning:** 5.3/8
  - (+) `steps[1]`: "Identified conclusion tier as human therapeutic (company claims about pharmacological exercise mimetic for humans)"
    _Most informative reasoning step_
  - Note: 6 reasoning steps
  - Note: Low step utility: 1/6 steps contribute

**Assumption Discipline:** 4.8/6
  - (+) `assumptions[1]`: "The company is making claims about human therapeutic potential"
    _Most substantive assumption_
  - Note: 3/3 substantive assumptions

**Uncertainty Handling:** 3.6/6
  - (+) `uncertainties[0]`: "Exact wording of company's claims - summary may be paraphrasing"
    _Most substantive uncertainty_
  - (+) `confidence`: "confidence: 0.9"
    _Stated confidence level_
  - (-) `uncertainties[0]`: "Exact wording of company's claims - summary may be paraphrasing"
    _Listed but never addressed in reasoning_
  - Note: 3 uncertainties (3 substantive)
  - Note: 1 decorative uncertainty(ies)

**Alternative Hypothesis Quality:** 4.5/6
  - (+) `alternative_hypotheses[1]`: "Could be overclaim if making broader population claims beyond the specific conditions tested"
    _Most substantive alternative hypothesis_
  - Note: 2 alternative hypotheses considered
  - Note: 2/2 genuinely diverse alternatives

**Self Monitoring Quality:** 1.2/8
  - (+) `self_check[2]`: "Checked that I'm not overflagging - the company is making human therapeutic claims"
    _Most substantive self-verification step_
  - (-) `self_check[0]`: "Confirmed this is animal-to-human bridge, not just animal results"
    _Fluff self-check_
  - Note: 4 self-check items
  - Note: Self-check quality: 0 deep, 1 arithmetic, 3 fluff

**Mechanism Quality:** 3.0/10
  - (+) `(mechanism analysis)`: "Classified as mechanism_vs_evidence due to unsupported leap from animal evidence to human therapeutic claims"
    _Mechanism description_
  - Note: Describes mechanism but does not name concept

**Communication Efficiency:** 10.0/10
  - Note: Signal density: 0.75, 204 words

**Insight Depth:** 8.0/8
  - Note: Key insights: 2 full / 2


## Failure Analysis

### Claude Sonnet

**STYLISTIC:**
- **Decorative Uncertainty** `[HEURISTIC]`: Uncertainty 'Exact wording of company's claims - summary may be paraphras...' is listed but not addressed
  - `uncertainties[0]`: "Exact wording of company's claims - summary may be paraphrasing"
  - _Impacts: uncertainty_handling_


## Consistency & Grounding Audit

### Claude Sonnet

- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 1 has low overlap with final answer (0/6 content words)
  - `key_claims[0]`: "Animal studies show metabolic and cardiac benefits"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 2 has low overlap with final answer (0/6 content words)
  - `key_claims[1]`: "Company positions this as potential human 'exercise mimetic'"
- **[WARN]** `[HEURISTIC]` `answer_claim_alignment`: Key claim 3 has low overlap with final answer (1/7 content words)
  - `key_claims[2]`: "Clear gap between mouse evidence and human therapeutic implications"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 1 is stated without rejection reasoning
  - `alternative_hypotheses[0]`: "Could be solid if claims were limited to mouse model results"
- **[NOTE]** `[HEURISTIC]` `weak_alternative`: Alternative hypothesis 2 is stated without rejection reasoning
  - `alternative_hypotheses[1]`: "Could be overclaim if making broader population claims beyond the specific conditions tested"
- **[NOTE]** `[MEDIUM CONFIDENCE]` `mechanism_gap`: Causal mechanism described but underlying concept not named
  - `final_answer`: "mechanism_vs_evidence"


## Agent Profiles

### Claude Sonnet (claude-sonnet-4-20250514)
**Parse OK:** True | **Latency:** 10928ms

**Final Answer:** mechanism_vs_evidence

**Confidence:** 0.9

**Assumptions:**
- The study was conducted in mouse models
- The company is making claims about human therapeutic potential
- No human data is presented in this summary

**Reasoning Steps:**
1. Identified evidence tier as animal studies (obese/diabetic mice, heart-failure model)
2. Identified conclusion tier as human therapeutic (company claims about pharmacological exercise mimetic for humans)
3. Found clear bridge step from mouse studies to human therapeutic implications
4. Evaluated whether bridge is supported - no human data provided
5. Noted that preparing for human trials acknowledges the gap but doesn't close it
6. Classified as mechanism_vs_evidence due to unsupported leap from animal evidence to human therapeutic claims

**Key Claims:**
- Animal studies show metabolic and cardiac benefits
- Company positions this as potential human 'exercise mimetic'
- Clear gap between mouse evidence and human therapeutic implications

**Alternative Hypotheses:**
- Could be solid if claims were limited to mouse model results
- Could be overclaim if making broader population claims beyond the specific conditions tested

**Uncertainties:**
- Exact wording of company's claims - summary may be paraphrasing
- Whether additional preclinical data beyond mice exists
- Strength of mechanistic rationale for human translation

**Self-Verification:**
- Confirmed this is animal-to-human bridge, not just animal results
- Verified no human data is mentioned
- Checked that I'm not overflagging - the company is making human therapeutic claims
- Confirmed the classification fits the evidence-conclusion mismatch

**Dimension Scores:**
- Correctness: 30.0/30 `##########`
- Support Strength: 2.4/8 `###.......`
- Structural Reasoning: 5.3/8 `######....`
- Assumption Discipline: 4.8/6 `########..`
- Uncertainty Handling: 3.6/6 `######....`
- Alternative Hypothesis Quality: 4.5/6 `#######...`
- Self Monitoring Quality: 1.2/8 `#.........`
- Insight Depth: 8.0/8 `##########`
- Mechanism Quality: 3.0/10 `###.......`
- Communication Efficiency: 10.0/10 `##########`


## Final Verdict

**Solo run: Claude Sonnet** scored **72.8/100**.

**Best per dimension:**
- Correctness: Claude Sonnet (30.0/30)
- Support Strength: Claude Sonnet (2.4/8)
- Structural Reasoning: Claude Sonnet (5.3/8)
- Assumption Discipline: Claude Sonnet (4.8/6)
- Uncertainty Handling: Claude Sonnet (3.6/6)
- Alternative Hypothesis Quality: Claude Sonnet (4.5/6)
- Self Monitoring Quality: Claude Sonnet (1.2/8)
- Insight Depth: Claude Sonnet (8.0/8)
- Mechanism Quality: Claude Sonnet (3.0/10)
- Communication Efficiency: Claude Sonnet (10.0/10)

**Latency vs Quality:**

| Agent | Latency | Score | Points/sec |
|-------|---------|-------|------------|
| Claude Sonnet | 10.9s | 72.8/100 | 6.7 |

Failure modes observed: decorative_uncertainty.
